Stockscreener 앱 받기
26.86
8.56%
-2.7046
Moderna Inc 주식(MRNA)의 최신 뉴스
Earnings call transcript: Moderna Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com India
Moderna Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Moderna falls as cost-cutting fails to appease investors - The Detroit News
Moderna CEO Attributes Full-Year Revenue Guidance Reduction To Timing Of Shipments: Retail Pins Hopes On Pipeline After Q2 Beat - Stocktwits
Moderna (MRNA) Wins Court Ruling Against Pfizer and BioNTech in Patent Dispute - GuruFocus
Moderna: Q2 Earnings Snapshot - The Washington Post
Apple, Amazon, Figma, MicroStrategy, Coinbase, Reddit, Moderna, and More Market Movers - Barron's
Moderna to lay off 10 percent of its workforce - CBS News
Moderna's Key Patent Win Overshadowed By Gloomy Outlook - Yahoo Finance
Pfizer/BioNTech lose bid to reverse Moderna COVID vaccine patent - Seeking Alpha
Moderna Falls as Cost-Cutting Fails to Appease Investors - MSN
Moderna drops after narrowing 2025 revenue outlook - MSN
Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo.co
Moderna (MRNA) Exceeds Expectations Despite Challenges - GuruFocus
Moderna stock drops after Q2 2025 results (MRNA:NASDAQ) - Seeking Alpha
Exxon Mobil, Eli Lilly, Moderna - TradingView
Earnings Snapshot:Moderna surpasses estimates;cutsFY top-end rev outlo - Seeking Alpha
Moderna, Inc Q2 Loss Decreases, Beats Estimates - Nasdaq
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates | MRNA Stock News - GuruFocus
Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops - Yahoo Finance
Moderna Stock Falls Again Amid Lowered Guidance, Job Cuts - inkl
Moderna's Q2 revenue slumps 41% to $142 million - breakingthenews.net
Moderna lowers top end of revenue guidance as vaccine group targets cost cuts - Investing.com Canada
Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts - Reuters
Moderna Q2 2025 slides: Revenue falls 41% as cost-cutting accelerates By Investing.com - Investing.com South Africa
Flu RNA Vaccines Market Set to Witness Significant Growth - openPR.com
Moderna Logs Sales Beat Despite Declining Vaccine Demand - The Wall Street Journal
Moderna’s Loss Narrows After Cost-Cutting Efforts Take Hold (MRNA) - Bloomberg.com
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates - Stock Titan
Pfizer losses appeal in Moderna patent case - breakingthenews.net
Pfizer and BioNTech lose appeal in Moderna COVID vaccine patent case - Investing.com Canada
UK Court of Appeal Confirms Moderna's EP'949 Patent is Valid and Infringed by Pfizer/BioNTech | MRNA Stock News - GuruFocus
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech - The Joplin Globe
Moderna Secures Major Patent Victory: UK Court Rules Pfizer Infringed COVID-19 Vaccine Technology - Stock Titan
Private Advisor Group LLC Sells 13,174 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Moderna to trim roughly 10% of global workforce - HRD America
Moderna plans to slash 10% of workforce as COVID shot sales slow - AOL.com
Moderna to Report Earnings as Cash Balance Shrinks - Barron's
Alnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast - Benzinga
Moderna's $1.5 Billion Cost-Cutting Strategy: A Double-Edged Sword for R&D, Efficiency, and Shareholder Value - AInvest
Moderna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it? - Fast Company
Vaccine maker Moderna cuts hundreds of jobs; CEO says 'every effort' made to avoid layoffs - The Business Journals
Moderna cuts staff amid operating 'uncertainty' - pharmaphorum
Moderna plans to lay off 10% of workforce to cut costs - Reuters
Moderna braces for deep Q2 loss as vaccine demand wanes - MSN
Moderna braces for deep Q2 loss as vaccine demand wanes (MRNA:NASDAQ) - Seeking Alpha
Cambridge-based Moderna to cut about 10% of its workforce - CBS News
Moderna to lay off 10% of workforce in ‘difficult but necessary step’ - BioPharma Dive
Nvidia, eBay, Moderna: Trending Tickers - Yahoo Finance
Moderna Slashes Global Workforce by 10% as $1.5B Cost Cuts Hit Home - BioSpace
Cambridge-based Moderna announces plan to cut workforce by 10% - WCVB
Moderna will lay off 10% of employees, Massachusetts-based company announces - CBS News
Moderna to lay off 10% of staff this year - MSN
Moderna gets EU nod for updated COVID-19 vaccine (MRNA) - Seeking Alpha
Moderna to lay off 10% of workforce - upi.com
Moderna Layoffs 2025: Biotech Giant to Cut 10% of Workforce Amid Cost Push - Deccan Herald
Moderna to cut more than 800 jobs this year as it burns through cash - MarketWatch
Moderna to lay off 10% of staff this year (MRNA:NASDAQ) - Seeking Alpha
Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles - Benzinga
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow - MSN
Moderna to cut 10% of global workforce, CEO Bancel says By Investing.com - Investing.com Canada
0.39%
0.52%
자본화:
|
볼륨(24시간):